Delayed sleep phase syndrome response to melatonin
In STEP 4, the extension of the STEP 1 trial of semaglutide, placebo patients regained around half their prior weight after a year
Compounded formulations, prepared by licensed pharmacies for individual patients, allow the addition of clinically chosen vitamins and amino acids that may help patients tolerate the medication better and feel better during weight loss
TRIUMPH-3 (1,949 patients with obesity and established cardiovascular disease) showed up to 22.6% weight loss at 80 weeks, plus meaningful improvements in triglycerides, blood pressure, and inflammatory markers
There is such thing as too much weight loss, and I hope this does not become something I see more often as a consequence of GLP-1 therapies